ADH-6 TFA

Please request pricing for this article.
Request Pricing

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T74443-5mg	5 mg				7 - 10 business days*		-
TGM-T74443-50mg	50 mg				7 - 10 business days*		-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: ADH-6 TFA, a tripyridylamide compound, effectively disrupts the self-assembly of the... more

Close menu

Product information "ADH-6 TFA"

Description: ADH-6 TFA, a tripyridylamide compound, effectively disrupts the self-assembly of the aggregation-nucleating subdomain of mutant p53 DBD, thereby targeting and disassociating mutant p53 aggregates in human cancer cells. This action restores the transcriptional activity of p53, resulting in cell cycle arrest and apoptosis. Consequently, ADH-6 TFA holds potential for cancer research [1]. Target: Others

Supplier:	TargetMol
Supplier-Nr:	T74443

Properties

MW:	754.67 D
Formula:	C31H37F3N8O11

Database Information

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "ADH-6 TFA"

Write a review